FDA's Proposed Rule For Oversight Of Laboratory Developed Tests: Part II: FDA's Proposed Phaseout Policy – Key Considerations & Open Questions - Healthcare
After an over decade-long discourse amongst interested stakeholders, on October 3, 2023, FDA unveiled its proposed rule and policy to increase oversight over LDTs.
York State Department Of Health Clinical Laboratory Evaluation Program Veterans Health Administration Public Health Surveillance Academic Medical Centers Amcs Clinical Laboratory Improvement Amendments
Source: mondaq.com